nx-2127
Nx 2127 is a drug used to treat Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), and other conditions. Nx 2127 is being actively studied in 1 study; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Nurix Therapeutics, Inc. | City of Hope | |
| MD Anderson Cancer Center | ||
| Memorial Sloan Kettering Cancer Center |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
- NX-2127
- Duarte, California
- +10 more
2022-03-25
Mar 25, 2022